

<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="https://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Avicenna J Med Biotech</journal-id>
      <journal-id journal-id-type="publisher-id">arij002</journal-id>
      <journal-title-group>
        <journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2008-2835</issn>
      <issn pub-type="epub">2008-4625</issn>
      <publisher>
        <publisher-name>Avicenna Research Institute</publisher-name>
      </publisher>
    </journal-meta>

    <article-meta>
      <article-id pub-id-type="publisher-id">ajmb274</article-id>
      <article-id pub-id-type="doi"></article-id>
      <article-id pub-id-type="pmid"></article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
             <subject></subject> 
        </subj-group>
        <subj-group>
            <subject></subject>
        </subj-group> 
      </article-categories>
      <title-group>
        <article-title>Development of Flow Cytometry-Fluorescent In Situ Hybridization (Flow-FISH) Method for Detection of PML/RARa Chromosomal Translocation in Acute Promyelocytic Leukemia Cell Line</article-title>
      </title-group>
        <contrib-group><contrib contrib-type="author"><name><surname>Zahedipour</surname><given-names>Fatemeh</given-names></name></contrib><aff>Department of Bioorganic Chemistry, Faculty of Chemistry, Wrocław University of Technology, Wroclaw, Poland</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Ranjbaran</surname><given-names>Reza</given-names></name></contrib><aff>Department of Anatomy, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Behzad-Behbahani</surname><given-names>Abbas</given-names></name></contrib><aff>Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Tavakol Afshari</surname><given-names>Khalil</given-names></name></contrib><aff>Dentofacial Deformities Research Center, Research Institute of Dental Sciences, Department of Orthodontic, Faculty of Dentistry, Shahid Behehsti University of Medical Sciences, Tehran, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Okhovat</surname><given-names>Mohammad Ali</given-names></name></contrib><aff>Research and Development Department, CinnaGen, Simindasht Industrial Area, Karaj, Iran</aff></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Tamadon</surname><given-names>Gholamhossein</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="author"><name><surname>Sharifzadeh</surname><given-names>Sedigheh</given-names></name></contrib><aff>Research and Development Department, CinnaGen, Simindasht Industrial Area, Karaj, Iran</aff></contrib-group>
      <pub-date pub-type="ppub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <pub-date pub-type="epub">
        <day></day>
        <month></month>
        <year></year>
      </pub-date>
      <volume>9</volume>
      <issue>2</issue>
      <fpage>104</fpage>
      <lpage>108</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </history>
      <abstract>
      <p>
      &lt;p&gt;Background: Acute Promyelocytic Leukemia (APL) is a subclass of acute myeloid leukemia. The chromosomal aberration in 95% of APL cases is t(15; 17) (q22; q21), which prevents cell differentiation. Characterization of the underlying molecular lesion is valuable in determining optimal treatment strategy. The goal of this study was to develop a new and powerful Flow- FISH technique to detect the long isoform (L) of PML-RARa fusion transcript in NB4 cell line.&lt;br /&gt;
Methods: To achieve the best condition for fixation, two different fixatives including 2% paraformaldehyde and 75% ethanol were used. 0.2% Triton X-100 and 0.2% saponin were used for the permeabilization step .In hybridization, a wide range of times and temperatures were used and probe was designed in FRET system. Results were confirmed by fluorescent microscope assay and reverse transcription PCR.&lt;br /&gt;
Results: In the present study, a novel technique was successfully optimized that combines in situ hybridization with flow cytometry to detect the presence of PML-RARa transcript. Using standard fixation and permeabilization protocol of 2% PFA and 0.2% saponin gave the best fluorescent results in flow cytometry. Also, results indicated that the optimum time and temperature for hybridization was 2 &lt;em&gt;hr&lt;/em&gt; at 42&lt;sup&gt;o&lt;/sup&gt;&lt;em&gt;C&lt;/em&gt;. The results of reverse transcription PCR and fluorescent microscopy confirmed the presence of PML-RARa transcript.&lt;br /&gt;
Conclusion: The concordance between the results of Flow-FISH and those of two other techniques including reverse transcription PCR and FISH indicated that this method would be applicable as a diagnostic test for APL in clinical samples and MRD monitoring.&lt;/p&gt;

      </p>
      </abstract>
    </article-meta>
  </front>
    
</article>
